Janssen CarePath for SIMPONI ARIA® (golimumab)
Providing access, affordability, and treatment support to help your patients start and stay on Janssen medications as prescribed
Helping to verify
and assisting with
the prior authorization
and appeals processes
that may be available
for your patients
patient support resources
Call us. We’re here to help.
*$20,000 maximum program benefit each calendar year. Program does not cover cost to give your patients' infusion. Not valid for patients using Medicare, Medicare Part D, Medicaid or other government funded programs. No income requirement. Click here for full eligibility requirements.
TRICARE is a registered trademark of the Department of Defense (DoD), DHA.
The information provided represents no statement, promise, or guarantee of Janssen Biotech, Inc., concerning levels of reimbursement, payment, or charge. Please consult your payer organization with regard to local or actual coverage, reimbursement policies, and determination processes.
Information is subject to change without notice. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility of Janssen Biotech, Inc.